...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith new VP
Reply New Message
Back To Forum List View
Zenith new VP
3
frohlir944-yahoo-com
Jul 28, 2017 11:55PM
Re: Zenith new VP
2
frohlir944-yahoo-com
Jul 29, 2017 12:03AM
Icon president Re: Zenith new VP
1
SanFrancisco99
Jul 29, 2017 12:17AM
Re: Zenith new VP
3
masila
Jul 29, 2017 06:48PM
Icon president Re: Zenith new VP
1
SanFrancisco99
Jul 29, 2017 07:12PM
Icon president Re: Zenith new VP
3
BearDownAZ
Jul 30, 2017 08:49AM
Re: Zenith new VP
3
Nextblockbuster
Jul 30, 2017 12:44PM
Re: Zenith new VP
2
tada
Jul 31, 2017 12:31AM
Icon president Re: Zenith new VP

SanFrancisco99
Jul 31, 2017 01:09AM
Re: Zenith new VP
2
tada
Jul 31, 2017 09:07AM
Icon president Re: Zenith new VP

SanFrancisco99
Jul 31, 2017 11:09AM
Re: Zenith new VP

tada
Jul 31, 2017 09:15PM
Icon president Re: Zenith new VP

SanFrancisco99
Aug 01, 2017 10:03AM
Icon president Re: Zenith new VP
1
BearDownAZ
Aug 01, 2017 10:59AM
Icon president Re: Zenith new VP

SanFrancisco99
Aug 01, 2017 11:04AM
Re: Zenith new VP
1
Nextblockbuster
Aug 01, 2017 12:57PM
Icon president Re: Zenith new VP
2
SanFrancisco99
Aug 01, 2017 01:37PM
Re: Zenith new VP

Hartland
Aug 01, 2017 06:16PM
Re: Zenith new VP
1
tada
Aug 02, 2017 01:05AM
Icon president Re: Zenith new VP

SanFrancisco99
Aug 02, 2017 09:56AM
Icon president Re: Zenith new VP
2
BearDownAZ
Aug 03, 2017 12:19PM
Icon president Re: Zenith new VP
3
SanFrancisco99
Aug 03, 2017 12:33PM
Icon president Re: Zenith new VP
4
BearDownAZ
Aug 03, 2017 12:57PM

Haven't heard too much from Edward van der Horst since he was brought on in July.  Is he helping to promote ZEL to a potential suitor who may be interested in ZEN 3694 or is he strictly on the science side of things?  It would be nice to hear some progress on this front.  I hope they haven't given up.

masila

2 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply